BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35646079)

  • 1. The Landscape of the Tumor-Infiltrating Immune Cell and Prognostic Nomogram in Colorectal Cancer.
    Zhong J; Qin Y; Yu P; Xia W; Gu B; Qian X; Hu Y; Su W; Zhang Z
    Front Genet; 2022; 13():891270. PubMed ID: 35646079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Establishment of a prediction model for colorectal cancer immune cell infiltration based on the cancer genome atlas (TCGA) database].
    Ding TT; Zeng CX; Hu LN; Yu MH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 54(2):203-208. PubMed ID: 35435180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Landscape of Immune Cells Infiltrating in Prostate Cancer.
    Wu Z; Chen H; Luo W; Zhang H; Li G; Zeng F; Deng F
    Front Oncol; 2020; 10():517637. PubMed ID: 33194581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of colorectal cancer.
    Ge P; Wang W; Li L; Zhang G; Gao Z; Tang Z; Dang X; Wu Y
    Biomed Pharmacother; 2019 Oct; 118():109228. PubMed ID: 31351430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-Infiltrating Immune Cells Act as a Marker for Prognosis in Colorectal Cancer.
    Ye L; Zhang T; Kang Z; Guo G; Sun Y; Lin K; Huang Q; Shi X; Ni Z; Ding N; Zhao KN; Chang W; Wang J; Lin F; Xue X
    Front Immunol; 2019; 10():2368. PubMed ID: 31681276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analyses of the heterogeneity and prognostic significance of tumor-infiltrating immune cells in non-small-cell lung cancer: Development and validation of an individualized prognostic model.
    Pang Z; Chen X; Wang Y; Wang Y; Yan T; Wan J; Du J
    Int Immunopharmacol; 2020 Sep; 86():106744. PubMed ID: 32623229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and validation of an immune prognostic signature in colorectal cancer.
    Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
    Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiles of immune infiltration in colorectal cancer and their clinical significant: A gene expression-based study.
    Xiong Y; Wang K; Zhou H; Peng L; You W; Fu Z
    Cancer Med; 2018 Sep; 7(9):4496-4508. PubMed ID: 30117315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of Tumor-Infiltrating Immune Cells in the Prognosis of Colon Cancer.
    Wu D; Ding Y; Wang T; Cui P; Huang L; Min Z; Xu M
    Onco Targets Ther; 2020; 13():4581-4589. PubMed ID: 32547088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low tumor infiltrating mast cell density confers prognostic benefit and reflects immunoactivation in colorectal cancer.
    Mao Y; Feng Q; Zheng P; Yang L; Zhu D; Chang W; Ji M; He G; Xu J
    Int J Cancer; 2018 Nov; 143(9):2271-2280. PubMed ID: 29873076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The establishment of immune infiltration based novel recurrence predicting nomogram in prostate cancer.
    Meng J; Liu Y; Guan S; Fan S; Zhou J; Zhang M; Liang C
    Cancer Med; 2019 Sep; 8(11):5202-5213. PubMed ID: 31355524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma.
    Yao J; Duan L; Huang X; Liu J; Fan X; Xiao Z; Yan R; Liu H; An G; Hu B; Ge Y
    Front Oncol; 2021; 11():769727. PubMed ID: 34926275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiles of immune cell infiltration in head and neck squamous carcinoma.
    Liang B; Tao Y; Wang T
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32095823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A gene expression-based study on immune cell subtypes and glioma prognosis.
    Zhong QY; Fan EX; Feng GY; Chen QY; Gou XX; Yue GJ; Zhang GH
    BMC Cancer; 2019 Nov; 19(1):1116. PubMed ID: 31729963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences of the immune cell landscape between normal and tumor tissue in human prostate.
    Zhang E; Dai F; Mao Y; He W; Liu F; Ma W; Qiao Y
    Clin Transl Oncol; 2020 Mar; 22(3):344-350. PubMed ID: 31077088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a macrophages-related 4-gene signature and nomogram for the overall survival prediction of hepatocellular carcinoma based on WGCNA and LASSO algorithm.
    Yang Z; Zi Q; Xu K; Wang C; Chi Q
    Int Immunopharmacol; 2021 Jan; 90():107238. PubMed ID: 33316739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA MIAT Services as a Noninvasive Biomarker for Diagnosis and Correlated with Immune Infiltrates in Breast Cancer.
    Ye T; Feng J; Cui M; Yang J; Wan X; Xie D; Liu J
    Int J Womens Health; 2021; 13():991-1004. PubMed ID: 34712062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapk14 is a Prognostic Biomarker and Correlates with the Clinicopathological Features and Immune Infiltration of Colorectal Cancer.
    Wang D; Peng L; Hua L; Li J; Liu Y; Zhou Y
    Front Cell Dev Biol; 2022; 10():817800. PubMed ID: 35141222
    [No Abstract]   [Full Text] [Related]  

  • 19. SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer.
    Li T; Yan Z; Wang W; Zhang R; Gan W; Lv S; Zeng Z; Hou Y; Yang M
    Front Mol Biosci; 2021; 8():687319. PubMed ID: 34938771
    [No Abstract]   [Full Text] [Related]  

  • 20. Immune signature of tumor-infiltrating immune cells predicts the prognosis and therapeutic effects in squamous cell carcinoma.
    Che Y; Luo Z; Zhang C; Sun N; Gao S; He J
    Int Immunopharmacol; 2020 Oct; 87():106802. PubMed ID: 32745903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.